Andrei H Iagaru - Stanford Medicine Children's Health
Andrei Iagaru, MD
Professor
Nuclear Radiology
Stanford Hospital
Nuclear Medicine
300 Pasteur Drive, Rm H2230 MC 5281
Stanford, CA 94305
Phone: [(650) 723-4000](tel:+1650 7234000)
Locations
Nuclear Medicine
300 Pasteur Drive, Rm H2230 MC 5281
Stanford, CA 94305
Phone : (650) 723-4000 723-4000)
Services
Work and Education
Professional Education
- Carol Davila University of Medicine, Bucharest, Romania, 2000
Residency
- University of Southern California Keck School of Medicine, Los Angeles, CA, 2005
- Stanford University Medical Center, Stanford, CA, 2006
Fellowship
- Stanford University Medical Center, Stanford, CA, 2007
Internship
- Graduate Hospital (Closed), Philadelphia, PA, 2004
Board Certifications
- Nuclear Medicine, American Board of Nuclear Medicine, 2006
Publications
1. Association of Early Same-Day Posttherapy Whole-Body SPECT/CT Using Visual RECIP 1.0 with Overall Survival During [177Lu]Lu-PSMA-617 Therapy for Metastatic Castration-Resistant Prostate Cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Park, H. L., Kersting, D., Bergstrom, C. P., Khaki, A. R., Shah, J., Davidzon, G. A., Moradi, F., Fan, A., Shah, S. A., Grady, E., Srinivas, S., Iagaru, A., Song, H. 2026
Abstract
This article evaluates whether early same-day posttherapy whole-body SPECT/CT assessed using visual RECIP 1.0 is associated with overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC) that is positive for prostate-specific membrane antigen (PSMA) and treated with [177Lu]Lu-PSMA-617.
View details for DOI 10.2967/jnumed.126.272651
2. Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics.
European urology Fanti, S., Turco, F., Tombal, B., Walz, J., Hofman, M. S., Hadaschik, B., Emmett, L., Tilki, D., Pecoraro, G., Salfi, G., Attard, G., Beltran, H., Bjartell, A., Briganti, A., Burger, I. A., Castro, E., Cerci, J. J., Chiti, A., Cooperberg, M., Fizazi, K., Fossati, N., Gafita, A., Gallina, A., Goffin, K., Horvath, L. G., Hugosson, J., Iagaru, A., James, N. D., Kasivisvanathan, V., Koh, D. M., Kristiansen, G., Kumar, R., Lecouvet, F., Loeb, S., McKay, R. R., Morris, M. J., Murphy, D. G., Murthy, V., Naoun, N., Oprea-Lager, D. E., Ost, P., O'Sullivan, J., Padhani, A. R., Palapattu, G., Paone, G., Petralia, G., Roobol, M. J., Sartor, O. A., Sathekge, M., Schuster, D. M., Seibert, T. M., Spratt, D. E., Tempany, C., Tunariu, N., Vargas, H. A., Vogl, U. M., Wyatt, A. W., Zilli, T., Lin, H. M., Omlin, A., Gillessen, S., Herrmann, K. 2026
View details for DOI 10.1016/j.eururo.2026.06.009
3. Is there a role for early SSTR-targeting PRRT in GEP-NET?
European journal of nuclear medicine and molecular imaging Ricciardello, G., Celesti, G., Bauckneht, M., Burger, I. A., Iagaru, A., Arco, M., Curatolo, S., Pagano, B., Amato, E., Auditore, L., Fiorillo, L., Piras, A., Piscopo, L., Shariftabrizi, A., Berretta, M., Vinci, S. L., Minutoli, F., Laudicella, R. 2026
View details for DOI 10.1007/s00259-026-07974-4
4. AcTFirst: A phase 3 trial of 225Ac-PSMA-617 plus ARPI versus standard of care in adults with PSMA-positive metastatic castration-resistant prostate cancer.
View details for DOI 10.1200/JCO.2026.44.16_suppl.TPS5134
5. Phase 1 Study of [177Lu]Lu-NeoB in Patients with Advanced Solid Tumors Overexpressing Gastrin-Releasing Peptide Receptor: Preliminary Safety and Dosimetry Results.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Mittra, E. S., Solnes, L. B., van der Veldt, A. A., Wong, J., Aloj, L., Heinrich, M. C., Chen, C. T., Rowe, S. P., Brabander, T., Pacey, S., Aimone, P., Pathak, D., Blumenstein, L., Liu, Y., Iagaru, A. 2025